Crdl stock forecast.

Find the latest Cardiol Therapeutics Inc. (CRDL.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Crdl stock forecast. Things To Know About Crdl stock forecast.

Cardiol Therapeutics is an innovative company that develops drugs for heart patients. The company was established in 2017. Its headquarters is located in Canada. It is among the leading companies ...CA14161Y2006. Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for ...WebCRDL Stock Forecast: 2023, 2024, 2025, 2030#CardiolStock #CRDLStockStock analysis for Cardiol Therapeutics Inc (CRDL:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Find the latest Cardiol Therapeutics Inc. (CRDL.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Analyst Future Growth Forecasts. Earnings vs Savings Rate: CRDL is forecast to remain unprofitable over the next 3 years. Earnings vs Market: CRDL is forecast to remain …

52 Week Low Date 04/06/23. Market Cap 63.52M. Shares Out 64.13M. 10 Day Average Volume 0.14M. Dividend -. Dividend Yield -. Beta -. YTD % Change 107.84.

Oct 10, 2023 · Current price models forecast CRDL shares to reach between $2.21 and $6.00, with the median target at $3.47, 328% higher than its current price. The bullish appraisals share a common theme, which ... The four covering CRDL are bullish regarding the expected share price trajectory. Current price models forecast CRDL shares to reach between $2.21 and $6.00, with the median target at $3.47, 328% higher than its current price. The bullish appraisals share a common theme, which is the expectation for CRDL's lead treatment candidate, CardiolRx(TM ...Twitter share price volatility before delisting. Twitter’s historical stock price was in an upward trend from 2017 until it peaked at its all-time high of $77.63 a share on 1 March 2021. However, the share price declined in 2022, falling to $31.30 in February – its lowest level since July 2020.Aenza S.A.A. saw a decrease in short interest in October. As of October 31st, there was short interest totaling 11,100 shares, a decrease of 6.7% from the October 15th total of 11,900 shares. Based on an average daily trading volume, of 9,200 shares, the days-to-cover ratio is presently 1.2 days.

Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p.m. ET to 3:30 p.m. ET of the following day. Data provided ...

Track Virpax Pharmaceuticals Inc (VRPX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Nov 24, 2023 · Analyst Forecast. The average price target for CRDL is $4.50, which is 423.26% higher than the current price. The consensus rating is "Strong Buy". Price Target. $4.50. Price Target Difference. 423.26%. Analyst Consensus. Cordel Group Plc earnings per share revisions and analysts forecast | London Stock Exchange: CRDL | London Stock Exchange1,807.30 -3.70(-0.20%) Crude Oil 75.63 +0.09(+0.12%) Gold 2,003.90 +0.90(+0.04%) Advertisement Cardiol Therapeutics Inc. (CRDL) NasdaqCM - NasdaqCM Delayed …Alpine’s stock has gained 62.3% so far this year. In the past 60 days, estimates for Alpine’s 2023 loss per share have narrowed from $1.43 to $1.18, while those for 2024 have improved from a ...Current price models forecast CRDL shares to reach between $2.21 and $6.00, with the median target at $3.47, 328% higher than its current price. The bullish appraisals share a common theme, which ...searchCompare to. Cardiol Therapeutics Inc. $1.26. CRDL 1.61%. AKUMIN INC. $0.43. AKU 0.00%. FSD Pharma Inc. $1.05. HUGE 0.019%. Immunoprecise Antibodies Ltd.News and fundamental data provided by Digital Look. Deal for just £11.95 per trade in a Stocks and Shares ISA , Lifetime ISA , SIPP or Fund and Share Account.

The stock price of CRDL is 0.86 while Cardiol Therapeutics 20-day EMA is 0.83, which makes it a Buy. Cardiol Therapeutics 50-day exponential moving average is 0.85 while CRDL share price is 0.86, making it a Buy technically. CRDL stock price is 0.86 and Cardiol Therapeutics 200-day simple moving average is 0.85, creating a Buy signal.Cardiol Therapeutics Stock Forecast 2023. In the last five quarters, Cardiol Therapeutics’s Price Target has risen from C$0.00 to C$1.20 - a 100% increase. 0 analysts predict that Cardiol Therapeutics’s share price will increase in the coming year, reaching C$4.50. This would represent an increase of 275%.CRDL Cardiol Therapeutics Forecast 2023. Check the latest CRDL quote. Read market charts, analyst ratings and a financial calendar. CRDL Cardiol Therapeutics Forecast 2023. Check the latest CRDL quote. Read market charts, analyst ratings and a financial calendar. more > HOME; TRADING. AI Robots. Stocks & ETFs & FOREX. …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comWebCRDL Overview Stock Screener Earnings Calendar Sectors Nasdaq | CRDL U.S.: Nasdaq Cardiol Therapeutics Inc. Watch list NEW Set a price target alert Open Last Updated: …

Cardiol Therapeutics Inc Class A Stock Forecast, CRDL stock price prediction. Price target in 14 days: 0.980 USD. The best long-term & short-term Cardiol Therapeutics Inc Class …CRDL shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the ...

Nov 27, 2023 · How have CRDL shares performed in 2023? Cordel Group's stock was trading at GBX 6.25 on January 1st, 2023. Since then, CRDL shares have decreased by 17.6% and is now trading at GBX 5.15. View the best growth stocks for 2023 here. Oct 10, 2023 · Current price models forecast CRDL shares to reach between $2.21 and $6.00, with the median target at $3.47, 328% higher than its current price. The bullish appraisals share a common theme, which ... According to the issued ratings of 2 analysts in the last year, the consensus rating for Cardiol Therapeutics stock is Buy based on the current 2 buy ratings for CRDL. The average twelve-month price prediction for Cardiol Therapeutics is $3.00 with a high price target of $3.00 and a low price target of $3.00. Learn more on CRDL's analyst rating ... CRDL stock forecasts 2025, with some analysts predicting that the share price may be lower than it is now. If you are new to the field of investment, you should especially evaluate the opinions of experts. According to some experts’ Cardiol stock forecast and some CRDL stock news, the price may drop by about 33%.Cordel Group plc (CRDL) Ordinary 1p. Cordel Group plc (CRDL) Sell: 4.70p Buy: 5.40p No change. Market closed | Prices as at close on 20 November 2023 | Turn off streaming prices. Add to watchlist ... Dec 1, 2023 · A high-level overview of Cardiol Therapeutics Inc. (CRDL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Cordel Group Plc Forecast, Short-Term " CRDL" Stock Price Prognosis for Next Days Walletinvestor.com CRDL Forecast, Long-Term Price Predictions for Next Months and Year: 2023, 2024Robinhood Markets Stock Forecast 12-02-2023. Forecast target price for 12-02-2023: $ 8.99. Negative dynamics for Robinhood Markets shares will prevail with possible volatility of 4.496%. Pessimistic target level: 8.86. Optimistic target level: 9.28.Nov 15, 2023 · Future criteria checks 0/6. Cardiol Therapeutics is forecast to grow earnings and revenue by 36.6% and 90.1% per annum respectively while EPS is expected to grow by 37.8% per annum. Based on analysts offering 12 month price targets for CRDL in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

Find the latest Cardiol Therapeutics Inc. (CRDL.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.

CRDL: Cardiol Therapeutics EPS. Get the latest EPS stock quote information from Zacks Investment Research. ... * Price Target & Stock Forecast ; Full Company Report; ... (CRDL) Stock 09/27/23-8 ...

High Growth Revenue: Insufficient data to determine if CRDL's revenue is forecast to grow faster than 20% per year. Earnings per Share Growth Forecasts Future Return on EquityCRDL stock can be a good choice for the mid-term and long-term. As per CRDL stock forecast from analysts, company’s market cap can hit $1 billion before 2030. | Volta Stock Forecast Research and publish the best content.Cardiol Therapeutics Inc Class A Stock Price Forecast, "CRDL" Predictons for2023Nov 15, 2023 · Future criteria checks 0/6. Cardiol Therapeutics is forecast to grow earnings and revenue by 36.6% and 90.1% per annum respectively while EPS is expected to grow by 37.8% per annum. In a report released on November 16, Charles Duncan from Cantor Fitzgerald reiterated a Buy rating on Cardiol Therapeutics (CRDL - Research Report), with a price target of $4.00.The companys ...3 brokerages have issued 1-year price targets for NuScale Power's shares. Their SMR share price targets range from $7.50 to $14.50. On average, they expect the company's stock price to reach $11.33 in the next twelve months. This suggests a possible upside of 310.6% from the stock's current price.According to the issued ratings of 5 analysts in the last year, the consensus rating for Aeva Technologies stock is Moderate Buy based on the current 2 hold ratings and 3 buy ratings for AEVA. The average twelve-month price prediction for Aeva Technologies is $1.62 with a high price target of $2.00 and a low price target of $0.96.Analysts are making other forecast for CRDL stocks. According to the Cardiol therapeutics stock forecast , the highest price was determined as $ 3.18 for 12 …About the Cardiol Therapeutics Inc. Class A Common Shares stock forecast. As of 2023 November 18, Saturday current price of CRDL stock is 1.170$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).

Promising Performance and Positive Forecasts: CRDL Stock Shows Potential Increase in Value. CRDL stock had a promising performance on September 19, 2023, based on the information provided by CNN Money. The stock received positive forecasts from analysts, indicating a potential increase in value. According to the data, the 4 analysts offering 12 ...Oct 10, 2023 · The four covering CRDL are bullish regarding the expected share price trajectory. Current price models forecast CRDL shares to reach between $2.21 and $6.00, with the median target at $3.47, 328% higher than its current price. The bullish appraisals share a common theme, which is the expectation for CRDL's lead treatment candidate, CardiolRx(TM ... When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Instagram:https://instagram. best texas dental insurancewvvibots stockalb nyse The latest Cordel Group plc (CRDL) Ordinary 1p share price (CRDL). View recent trades and share price information for Cordel Group plc (CRDL) Ordinary 1p. advance auto parts stocksschwab private client services Cardiol Therapeutics is an innovative company that develops drugs for heart patients. The company was established in 2017. Its headquarters is located in Canada. It is among the leading companies ...Their GOSS share price targets range from $1.25 to $10.00. On average, they predict the company's stock price to reach $5.58 in the next twelve months. This suggests a possible upside of 674.6% from the stock's current price. View analysts price targets for GOSS or view top-rated stocks among Wall Street analysts.Web stock trading blogs Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company’s lead small molecule drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically ...Jun 28, 2023 · Cardiol Therapeutics' CEO is David Elsley, appointed in Jan 2017, has a tenure of 6.83 years. total yearly compensation is CA$653.80K, comprised of 80.3% salary and 19.7% bonuses, including company stock and options. directly owns 1.78% of the company’s shares, worth CA$1.36M. The average tenure of the management team and the board of ...